| Date | Source | Headline | |
|---|---|---|---|
| 12th Mar 2026 | 6:30 am | RNS-R | Ipsen appoints Michelle C. Werner as EVP, President of North America |
| 22nd Dec 2025 | 6:00 am | RNS-R | Ipsen expands early development pipeline with Simcere Zaiming's innovative antibody drug conjugate |
| 19th Dec 2025 | 6:00 am | RNS-R | Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP) |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.